Cogstate Ltd (OTCPK:COGZF)
$ 0.609 -0.00066 (-0.11%) Market Cap: 110.70 Mil Enterprise Value: 80.24 Mil PE Ratio: 19.03 PB Ratio: 2.65 GF Score: 70/100

Half Year 2024 CogState Ltd Earnings Call Transcript

Feb 21, 2024 / 09:30PM GMT
Release Date Price: $0.8371 (+2.28%)
Brad O;Connor
Cogstate Limited - CEO

' -

Good morning, everyone. Thank you for joining today's investor update, which include a discussion of our results for the half year result -- half year ended December 31, 2023. My name is Brad O'Connor, CEO of Cogstate. I'm going to be joined today by Darren Watson, who's our CFO, and by Rachel Colite, who's the Executive Vice President of our clinical trials business. Rachel has recently been promoted into that role and where she has full P&L responsibility for our clinical trials business. So excited to you to hear from her directly.

Today's presentation includes forward-looking statements. And therefore, I note our disclaimer [statement] information in this presentation is general in nature. I encourage all investors to consider your own investment objectives and also to review in detail our half year financial statements that have been lodged with the ASX this morning.

Following our presentation, we will take questions. If you have a question, there are two ways in which to ask that question. Firstly, you can type your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot